Aptose Biosciences Inc. (APS.TO) TSX

2.01

-0.09000001(-4.29%)

Updated at December 24 01:05PM

Currency In CAD

Valuation

Market Cap156.28M
Enterprise Value160.77M
P/E Ratio-0.31
PEG Ratio0.03
Price/Sales Ratio9.64
Price/Book Ratio-0.22
Enterprise/Revenue8.96
Enterprise/EBITDA0.22

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-31.28
Operating Margin41.08

Management Effectiveness

Return On Assets-2.23
Return On Equity1.24

Income Statement

Revenue0
Revenue/Share0.18
Gross Profit0
EBITDA-26.23M
Net Income-25.43M
Diluted EPS-0.13

Balance Sheet

Total Cash613,000
Total Cash/Share0.24
Total Debt19.02M
Total Debt/Equity-0.02
Current Ratio0.53
Book Value Per Share-7.62

Price History

52-Week Change456.25
52-Week High5.8
52-Week Low0.16
Moving Average 50 Days2.06
Moving Average 200 Days2.32

Statistics

Average Volume5,817
Shares Outstanding2.55M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:30
Last Split DateFebruary 26, 2025